We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
VanEck CEF Muni Income ETF
XMPT
$219M
| $59K | ﹤0.01% |
2,734
+381
| +16% | +$7.97K |
|
1302
YPF
YPF
$206B
| $59K | ﹤0.01% |
+6,375
| New | +$49.2K |
|
1303
Globant
GLOB
$1.58B
| $57K | ﹤0.01% |
341
+30
| +10% | +$5.31K |
|
|
ONEM
1304
DELISTED
1Life Healthcare
ONEM
| $57K | ﹤0.01% |
3,423
+1,210
| +55% | +$20.4K |
|
1305
10x Genomics
TXG
$6B
| $56K | ﹤0.01% |
1,525
+200
| +15% | +$6.54K |
|
|
CVGW
1306
DELISTED
Calavo Growers
CVGW
| $55K | ﹤0.01% |
1,861
+122
| +7% | +$4.09K |
|
1307
Sylvamo
SLVM
$1.49B
| $55K | ﹤0.01% |
1,129
+247
| +28% | +$11.9K |
|
|
ABCM
1308
DELISTED
Abcam PLC
ABCM
| $55K | ﹤0.01% |
3,536
+1,035
| +41% | +$16.2K |
|
1309
Evolent Health
EVH
$348M
| $54K | ﹤0.01% |
+1,937
| New | +$55.5K |
|
1310
VanEck International High Yield Bond ETF
IHY
$43.3M
| $53K | ﹤0.01% |
2,694
+2,279
| +549% | +$43K |
|
1311
Ituran Location and Control
ITRN
$1.09B
| $52K | ﹤0.01% |
2,445
-4,428
| -64% | -$101K |
|
1312
LSB Industries
LXU
$783M
| $52K | ﹤0.01% |
3,935
-87
| -2% | -$1.3K |
|
1313
Treace Medical Concepts
TMCI
$280M
| $52K | ﹤0.01% |
+2,274
| New | +$52.4K |
|
1314
iRhythm Holdings
IRTC
$3.85B
| $51K | ﹤0.01% |
544
+154
| +39% | +$16.8K |
|
1315
VTEX
VTEX
$735M
| $51K | ﹤0.01% |
13,560
-3,199
| -19% | -$12.2K |
|
1316
Algonquin Power & Utilities
AQN
$4.49B
| $48K | ﹤0.01% |
7,278
+1,080
| +17% | +$9.63K |
|
1317
VanEck BDC Income ETF
BIZD
$1.59B
| $48K | ﹤0.01% |
3,408
+2,822
| +482% | +$41.2K |
|
1318
VanEck Preferred Securities ex Financials ETF
PFXF
$2.41B
| $47K | ﹤0.01% |
2,822
+2,337
| +482% | +$39.8K |
|
|
JBTM
1319
JBT Marel
JBTM
$7.21B
| $46K | ﹤0.01% |
509
| – | – |
|
|
RCM
1320
DELISTED
R1 RCM Inc. Common Stock
RCM
| $46K | ﹤0.01% |
4,209
-1,041
| -20% | -$13.2K |
|
1321
Agilon Health
AGL
$1.53B
| $44K | ﹤0.01% |
110
+33
| +43% | +$15.5K |
|
1322
Beam Therapeutics
BEAM
$2.63B
| $44K | ﹤0.01% |
1,124
+408
| +57% | +$18.3K |
|
|
FPI
1323
Farmland Partners
FPI
$408M
| $44K | ﹤0.01% |
3,562
+1,985
| +126% | +$26.2K |
|
|
LKFT
1324
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $44K | ﹤0.01% |
998
+230
| +30% | +$9.68K |
|
|
BPMC
1325
DELISTED
Blueprint Medicines
BPMC
| $43K | ﹤0.01% |
986
+334
| +51% | +$16K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.